Accelerating drug development with AI
We’re harnessing technology to deliver better medicines to patients faster.
Innovation is more than invention – it's the relentless pursuit of better for patients
At AbbVie, we make smart bets, learn fast and move even faster, finding untapped opportunities to expand the reach of medicine far beyond expectations.
Explore the science shaping the future of medicine
AI & Data Convergence
We’re transforming R&D with artificial intelligence (AI), machine learning (ML) and an industry-leading data platform to help speed up the pace of discovery.
Genomics
With access to more than 1 million genomes, we’re leading one of the world’s largest genomics research efforts to better understand the drivers of disease.
Patient-focused drug development
From partnering with patients to leveraging digital health technologies, our scientists use novel approaches that apply patient insights and harness real data.
Precision medicine
Harnessing advanced technologies and a deep understanding of disease mechanisms to develop the right medicine for the right patient, faster.
Therapeutic modalities & platforms
Our versatile R&D toolbox includes cutting-edge modalities and platform technologies to create the best molecule for each target.
AbbVie Ventures
Fueling early-stage opportunities in oncology, immunology, neuroscience, eye care and aesthetics through AbbVie’s strategic venture capital arm.
The tools powering tomorrow’s discoveries
Behind every breakthrough is a technology pushing science further. From harnessing artificial intelligence in drug discovery, to advancing genetic medicine, our teams leverage powerful tools that can accelerate progress, working to transform ideas into medicines that can change lives.
ADCs in 60 Seconds
What are antibody-drug conjugates (ADCs)? Watch scientist Emily Faivre explain how ADCs work in this One Minute Thesis.
Multispecific Antibodies in 60 Seconds
Discover how multispecific antibodies are being used to discover new potential treatment options.
Shuttle Technology in 60 Seconds
Hear Alessandra Welker, PhD, explain how shuttle technology can help unlock new possibilities for treating neurological disorders and deliver medicines through the blood-brain barrier.
Help redefine what’s possible in medicine
Bring your expertise to a team where bold ideas and new technologies become real-world solutions for patients.
External links
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
